$61.56
-0.99-1.58%
Pre-Market: Apr 4, 7:57 PM EDT
Comments
Loading...
Novo Nordisk Stock Guidance | NYSE:NVO | Benzinga
Novo Nordisk issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/05/2025 | NVO | Novo Nordisk | FY | 2025 | — | — | — | $49.44B | $53.60B | $47.64B | Get Alert |
| 11/06/2024 | NVO | Novo Nordisk | FY | 2024 | — | — | — | $41.74B | $43.10B | $41.92B | Get Alert |
| 08/07/2024 | NVO | Novo Nordisk | FY | 2024 | — | — | — | $40.55B | $42.56B | $42.86B | Get Alert |
| 05/02/2024 | NVO | Novo Nordisk | FY | 2024 | — | — | — | $40.25B | $42.96B | $41.28B | Get Alert |
| 01/31/2024 | NVO | Novo Nordisk | FY | 2024 | — | — | — | $39.21B | $41.90B | $40.17B | Get Alert |
| 11/02/2023 | NVO | Novo Nordisk | FY | 2023 | — | — | — | $33.07B | $34.62B | $31.83B | Get Alert |
| 08/10/2023 | NVO | Novo Nordisk | FY | 2023 | — | — | — | $31.29B | $32.84B | $32.04B | Get Alert |
| 05/04/2023 | NVO | Novo Nordisk | FY | 2023 | — | — | — | $30.09B | $31.63B | $31.90B | Get Alert |
| 02/01/2023 | NVO | Novo Nordisk | FY | 2023 | — | — | — | $26.76B | $28.18B | $28.77B | Get Alert |
| 11/02/2022 | NVO | Novo Nordisk | FY | 2022 | — | — | — | $23.66B | $24.23B | $22.97B | Get Alert |
| 08/03/2022 | NVO | Novo Nordisk | FY | 2022 | — | — | — | $22.59B | $23.40B | $23.52B | Get Alert |
| 02/02/2022 | NVO | Novo Nordisk | FY | 2022 | — | — | — | $24.04B | $24.90B | $22.48B | Get Alert |
| 10/29/2021 | NVO | Novo Nordisk | Q3 | 2021 | — | — | — | $5.64B | $5.64B | $5.35B | Get Alert |
| 10/29/2021 | NVO | Novo Nordisk | FY | 2021 | — | — | — | $22.55B | $23.15B | $21.35B | Get Alert |
| 08/04/2021 | NVO | Novo Nordisk | FY | 2021 | — | — | — | $21.80B | $22.42B | $21.47B | Get Alert |
| 02/03/2021 | NVO | Novo Nordisk | FY | 2021 | — | — | — | $21.35B | $22.17B | $21.76B | Get Alert |
| 10/30/2020 | NVO | Novo Nordisk | FY | 2020 | — | — | — | $20.11B | $20.69B | $20.39B | Get Alert |
| 10/08/2020 | NVO | Novo Nordisk | Q3 | 2020 | — | — | — | $4.86B | $4.86B | $4.88B | Get Alert |
| 10/08/2020 | NVO | Novo Nordisk | FY | 2020 | — | — | — | $19.22B | $19.77B | $20.18B | Get Alert |
FAQ
What is the most recent guidance for Novo Nordisk (NVO)?
There have been no specific sales or earnings guidance reported for Novo Nordisk in recent months.
Browse guidance and forecast on all stocks.